Sodium perrhenate

CAS: 13472-33-8

Ref. 3D-NAA47233

Produktinformation

• Name: Sodium perrhenate
• Synonyme: Perrhenic acid (HReO₄), sodium salt, Perrhenic acid(HReO4), sodium salt (8CI), Rhenate (ReO41-), sodium (1:1), (T-4)-, Rhenate (ReO41-), sodium, (T-4)-, Rhenate (ReO₄^1-), sodium (1:1), (T-4)-, Rhenate (ReO₄^1-), sodium, (T-4)-, Rhenate(Reo4(sup 1-)), sodium, (T-4)- (9CI), Rhenium sodium oxide (ReNaO₄), Rhenium(VII) sodium oxide, Sodium Oxido(Trioxo)Rhenium, Sodium perrhenate (NaReO₄), Sodium rhenate, Sodium tetraoxorhenate(1-)

Beschreibung

Sodium perrhenate is a drug that is used for the treatment of cancer. It has been shown to be an effective drug for treating tumors in mice. This drug works by binding to a monoclonal antibody and targeting the tumor cells. The uptake of sodium perrhenate into the tumor cells can be increased by alkoxy radicals, which are generated internally as a result of oxygen metabolism. The pharmacokinetic properties of sodium perrhenate also make it a good candidate for treating tumors because it is stable and readily penetrates the blood-brain barrier. Sodium perrhenate also has been shown to have anticancer activity against various types of tumors, including those that are resistant to chemotherapy or radiation therapy.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 273.19 g/mol
• Formel: NaReO₄
• Reinheit: Min. 95%